| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 16 | 2025 | 536 | 3.030 |
Why?
|
| Tomography, Optical Coherence | 12 | 2021 | 569 | 2.410 |
Why?
|
| Maternal Exposure | 8 | 2023 | 154 | 1.990 |
Why?
|
| Prenatal Exposure Delayed Effects | 8 | 2016 | 243 | 1.970 |
Why?
|
| Smoking | 10 | 2025 | 1136 | 1.750 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 3 | 2025 | 78 | 1.670 |
Why?
|
| Bronchoscopy | 6 | 2021 | 173 | 1.660 |
Why?
|
| Nicotine | 5 | 2022 | 147 | 1.610 |
Why?
|
| Pregnancy | 41 | 2025 | 7570 | 1.400 |
Why?
|
| Epigenesis, Genetic | 7 | 2016 | 773 | 1.300 |
Why?
|
| Diet, High-Fat | 5 | 2016 | 241 | 1.270 |
Why?
|
| Premature Birth | 4 | 2025 | 418 | 1.260 |
Why?
|
| Electronic Nicotine Delivery Systems | 3 | 2017 | 58 | 1.010 |
Why?
|
| Zika Virus | 5 | 2023 | 151 | 1.000 |
Why?
|
| Image-Guided Biopsy | 3 | 2018 | 43 | 0.990 |
Why?
|
| Fetal Growth Retardation | 5 | 2024 | 257 | 0.960 |
Why?
|
| Asthma | 5 | 2021 | 810 | 0.940 |
Why?
|
| DNA Methylation | 6 | 2016 | 1148 | 0.830 |
Why?
|
| Histone Code | 2 | 2014 | 53 | 0.830 |
Why?
|
| Cyclonic Storms | 1 | 2023 | 80 | 0.780 |
Why?
|
| Dietary Fats | 3 | 2014 | 300 | 0.770 |
Why?
|
| Disasters | 1 | 2023 | 106 | 0.770 |
Why?
|
| Fetus | 6 | 2024 | 601 | 0.770 |
Why?
|
| Histones | 4 | 2014 | 573 | 0.770 |
Why?
|
| Lung Neoplasms | 3 | 2019 | 1787 | 0.760 |
Why?
|
| Lung | 3 | 2019 | 1577 | 0.730 |
Why?
|
| Bronchial Thermoplasty | 1 | 2021 | 1 | 0.730 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2012 | 51 | 0.710 |
Why?
|
| Muscle, Smooth | 3 | 2021 | 138 | 0.710 |
Why?
|
| Macaca | 5 | 2016 | 64 | 0.700 |
Why?
|
| Endotoxemia | 1 | 2021 | 56 | 0.680 |
Why?
|
| DNA Adducts | 2 | 2025 | 82 | 0.670 |
Why?
|
| Liver | 5 | 2014 | 1879 | 0.660 |
Why?
|
| Pregnancy Complications | 4 | 2020 | 553 | 0.660 |
Why?
|
| Placentation | 1 | 2020 | 61 | 0.640 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 629 | 0.640 |
Why?
|
| Allergens | 2 | 2019 | 278 | 0.630 |
Why?
|
| Perinatal Care | 1 | 2020 | 68 | 0.630 |
Why?
|
| Patient Outcome Assessment | 1 | 2020 | 94 | 0.630 |
Why?
|
| Environmental Pollution | 1 | 2019 | 16 | 0.620 |
Why?
|
| Female | 48 | 2025 | 71928 | 0.620 |
Why?
|
| Airway Remodeling | 1 | 2019 | 22 | 0.620 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2019 | 54 | 0.600 |
Why?
|
| Lung Diseases | 2 | 2013 | 404 | 0.590 |
Why?
|
| Scleroderma, Systemic | 1 | 2020 | 130 | 0.580 |
Why?
|
| Radiology, Interventional | 1 | 2018 | 35 | 0.580 |
Why?
|
| Eye | 1 | 2020 | 245 | 0.580 |
Why?
|
| Thyroid Hormones | 2 | 2015 | 71 | 0.570 |
Why?
|
| Zika Virus Infection | 5 | 2023 | 175 | 0.570 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2016 | 1051 | 0.560 |
Why?
|
| Infant, Newborn | 11 | 2025 | 8623 | 0.560 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 616 | 0.530 |
Why?
|
| Health Status Disparities | 1 | 2020 | 250 | 0.530 |
Why?
|
| Lymph Nodes | 1 | 2018 | 399 | 0.500 |
Why?
|
| Cytochrome P-450 CYP1A1 | 3 | 2012 | 83 | 0.500 |
Why?
|
| Respiratory System | 1 | 2016 | 98 | 0.500 |
Why?
|
| Microscopy | 1 | 2016 | 124 | 0.490 |
Why?
|
| Humans | 49 | 2025 | 134156 | 0.470 |
Why?
|
| Fetal Blood | 1 | 2015 | 178 | 0.460 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 128 | 0.450 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 20 | 0.440 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 28 | 0.410 |
Why?
|
| Epigenomics | 2 | 2012 | 196 | 0.410 |
Why?
|
| Esophagoscopy | 1 | 2014 | 165 | 0.400 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2012 | 22 | 0.400 |
Why?
|
| Gestational Age | 6 | 2025 | 1229 | 0.390 |
Why?
|
| Obesity | 4 | 2021 | 2446 | 0.390 |
Why?
|
| Esophagus | 1 | 2014 | 234 | 0.380 |
Why?
|
| Sirtuin 1 | 1 | 2012 | 56 | 0.380 |
Why?
|
| Birth Weight | 5 | 2016 | 354 | 0.380 |
Why?
|
| Pulmonary Medicine | 1 | 2012 | 26 | 0.370 |
Why?
|
| Thyroid Gland | 1 | 2012 | 117 | 0.370 |
Why?
|
| Chromatin | 1 | 2015 | 617 | 0.370 |
Why?
|
| Laser Therapy | 1 | 2014 | 227 | 0.370 |
Why?
|
| Optics and Photonics | 1 | 2012 | 123 | 0.350 |
Why?
|
| Adult | 19 | 2025 | 31945 | 0.340 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 85 | 0.330 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2009 | 4 | 0.320 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1761 | 0.320 |
Why?
|
| Animals | 18 | 2024 | 36557 | 0.320 |
Why?
|
| Air Pollution | 2 | 2023 | 75 | 0.320 |
Why?
|
| Acetylation | 3 | 2015 | 195 | 0.310 |
Why?
|
| Barrett Esophagus | 1 | 2014 | 358 | 0.310 |
Why?
|
| Cannabis | 2 | 2022 | 52 | 0.310 |
Why?
|
| Diabetes, Gestational | 2 | 2024 | 115 | 0.300 |
Why?
|
| Environment | 1 | 2009 | 156 | 0.300 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2018 | 486 | 0.300 |
Why?
|
| Bronchial Diseases | 1 | 2008 | 12 | 0.300 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 298 | 0.290 |
Why?
|
| Dogs | 2 | 2021 | 798 | 0.280 |
Why?
|
| Fibrosis | 2 | 2020 | 463 | 0.280 |
Why?
|
| Bronchi | 2 | 2021 | 108 | 0.270 |
Why?
|
| Models, Animal | 4 | 2024 | 486 | 0.270 |
Why?
|
| Image Enhancement | 1 | 2008 | 173 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 2669 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 872 | 0.260 |
Why?
|
| DNA | 1 | 2011 | 1682 | 0.240 |
Why?
|
| Benzo(a)pyrene | 1 | 2025 | 26 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 1071 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 1433 | 0.230 |
Why?
|
| Genome, Human | 1 | 2011 | 1351 | 0.220 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2024 | 85 | 0.220 |
Why?
|
| Male | 12 | 2025 | 66127 | 0.220 |
Why?
|
| Ozone | 1 | 2023 | 21 | 0.210 |
Why?
|
| Causality | 1 | 2023 | 94 | 0.210 |
Why?
|
| Climate Change | 1 | 2023 | 62 | 0.200 |
Why?
|
| Macaca mulatta | 1 | 2024 | 513 | 0.200 |
Why?
|
| Body Mass Index | 3 | 2020 | 1719 | 0.200 |
Why?
|
| Metformin | 1 | 2024 | 165 | 0.190 |
Why?
|
| Histone Deacetylases | 2 | 2013 | 125 | 0.190 |
Why?
|
| Air Pollutants | 1 | 2023 | 113 | 0.190 |
Why?
|
| Data Accuracy | 1 | 2021 | 32 | 0.180 |
Why?
|
| Proglucagon | 1 | 2021 | 5 | 0.180 |
Why?
|
| Machine Learning | 1 | 2025 | 339 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2023 | 246 | 0.180 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2022 | 94 | 0.170 |
Why?
|
| Trophoblasts | 2 | 2023 | 119 | 0.170 |
Why?
|
| CpG Islands | 2 | 2012 | 347 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2013 | 1140 | 0.170 |
Why?
|
| Birth Certificates | 1 | 2020 | 13 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 399 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 490 | 0.170 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 136 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2020 | 31 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2198 | 0.160 |
Why?
|
| Bleomycin | 1 | 2020 | 153 | 0.160 |
Why?
|
| Microscopy, Polarization | 1 | 2019 | 11 | 0.160 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3668 | 0.160 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 123 | 0.160 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 319 | 0.160 |
Why?
|
| Bronchial Provocation Tests | 1 | 2019 | 15 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2021 | 451 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 526 | 0.150 |
Why?
|
| Bayes Theorem | 1 | 2020 | 316 | 0.150 |
Why?
|
| Collagen | 1 | 2020 | 330 | 0.150 |
Why?
|
| Embryo Loss | 1 | 2018 | 26 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 215 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 703 | 0.150 |
Why?
|
| Weight Gain | 1 | 2021 | 413 | 0.150 |
Why?
|
| Refraction, Ocular | 1 | 2020 | 217 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2023 | 951 | 0.140 |
Why?
|
| Physicians, Family | 1 | 2017 | 38 | 0.140 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2017 | 32 | 0.140 |
Why?
|
| Gene Expression | 2 | 2012 | 1621 | 0.140 |
Why?
|
| Transcriptome | 1 | 2024 | 1138 | 0.140 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 85 | 0.130 |
Why?
|
| Mice | 6 | 2023 | 19055 | 0.130 |
Why?
|
| Obstetrics | 2 | 2017 | 240 | 0.130 |
Why?
|
| Muscle Relaxation | 1 | 2016 | 16 | 0.130 |
Why?
|
| Birefringence | 1 | 2016 | 12 | 0.130 |
Why?
|
| Virus Replication | 2 | 2018 | 637 | 0.130 |
Why?
|
| Eutheria | 1 | 2016 | 2 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 249 | 0.130 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 132 | 0.130 |
Why?
|
| Residence Characteristics | 2 | 2016 | 293 | 0.130 |
Why?
|
| Cartilage | 1 | 2016 | 51 | 0.130 |
Why?
|
| Metabolome | 1 | 2019 | 322 | 0.130 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 920 | 0.130 |
Why?
|
| Birth Rate | 1 | 2016 | 17 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2018 | 224 | 0.130 |
Why?
|
| Epidemics | 1 | 2017 | 59 | 0.130 |
Why?
|
| Smoke | 2 | 2022 | 68 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 178 | 0.130 |
Why?
|
| Sus scrofa | 1 | 2016 | 128 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 67 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 33 | 0.130 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2016 | 45 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2016 | 174 | 0.120 |
Why?
|
| Thyrotropin | 1 | 2015 | 62 | 0.120 |
Why?
|
| Vehicle Emissions | 1 | 2016 | 20 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 1167 | 0.120 |
Why?
|
| Th2 Cells | 1 | 2016 | 190 | 0.120 |
Why?
|
| Triiodothyronine | 1 | 2015 | 73 | 0.120 |
Why?
|
| Fast Foods | 1 | 2015 | 35 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 167 | 0.120 |
Why?
|
| Thyroxine | 1 | 2015 | 76 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 1310 | 0.120 |
Why?
|
| Biopsy | 1 | 2019 | 1304 | 0.120 |
Why?
|
| Texas | 3 | 2019 | 3716 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 130 | 0.120 |
Why?
|
| Commerce | 1 | 2015 | 57 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2017 | 482 | 0.120 |
Why?
|
| Methylation | 1 | 2015 | 232 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1923 | 0.110 |
Why?
|
| Focus Groups | 1 | 2015 | 212 | 0.110 |
Why?
|
| Food Supply | 1 | 2015 | 101 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3754 | 0.110 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2014 | 20 | 0.110 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2015 | 184 | 0.110 |
Why?
|
| Hypersensitivity | 1 | 2016 | 194 | 0.110 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 365 | 0.110 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 182 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 723 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2015 | 252 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1416 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 207 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1979 | 0.100 |
Why?
|
| Disease Progression | 1 | 2020 | 2266 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 3506 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 237 | 0.100 |
Why?
|
| Iodide Peroxidase | 1 | 2012 | 10 | 0.100 |
Why?
|
| Pre-Eclampsia | 2 | 2016 | 227 | 0.100 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 227 | 0.100 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 34 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 250 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 40 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 387 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 52 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 367 | 0.100 |
Why?
|
| Hamartoma | 1 | 2013 | 53 | 0.100 |
Why?
|
| Patient Selection | 1 | 2016 | 735 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 632 | 0.100 |
Why?
|
| COS Cells | 1 | 2012 | 284 | 0.100 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 580 | 0.100 |
Why?
|
| Biomarkers | 2 | 2020 | 3434 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1492 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2012 | 313 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2012 | 176 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2012 | 178 | 0.090 |
Why?
|
| Lysine | 1 | 2012 | 207 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2013 | 112 | 0.090 |
Why?
|
| Mass Screening | 2 | 2017 | 840 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2015 | 721 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1157 | 0.090 |
Why?
|
| Hypothyroidism | 1 | 2012 | 100 | 0.090 |
Why?
|
| Fetal Development | 1 | 2012 | 135 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 738 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 4808 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 370 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2014 | 827 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2012 | 223 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2010 | 29 | 0.090 |
Why?
|
| Aged | 3 | 2021 | 21775 | 0.080 |
Why?
|
| Middle Aged | 4 | 2021 | 29399 | 0.080 |
Why?
|
| Young Adult | 4 | 2020 | 9944 | 0.080 |
Why?
|
| Risk Factors | 3 | 2020 | 11182 | 0.080 |
Why?
|
| Genetics, Behavioral | 1 | 2009 | 10 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1332 | 0.080 |
Why?
|
| United States | 3 | 2020 | 11763 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2014 | 1493 | 0.080 |
Why?
|
| Interferometry | 1 | 2009 | 25 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 261 | 0.080 |
Why?
|
| Maternal Behavior | 1 | 2009 | 71 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 124 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2009 | 81 | 0.070 |
Why?
|
| Inflammation | 1 | 2016 | 1595 | 0.070 |
Why?
|
| Rats | 1 | 2015 | 3890 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 133 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7217 | 0.070 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 142 | 0.070 |
Why?
|
| User-Computer Interface | 1 | 2008 | 167 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 317 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2009 | 789 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2015 | 3743 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2011 | 877 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 937 | 0.060 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2025 | 31 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2010 | 845 | 0.060 |
Why?
|
| Microcephaly | 2 | 2018 | 354 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 4598 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2915 | 0.050 |
Why?
|
| Pericytes | 1 | 2023 | 25 | 0.050 |
Why?
|
| Enoxacin | 1 | 2023 | 5 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2017 | 915 | 0.050 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2023 | 13 | 0.050 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 21 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2024 | 91 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 78 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 2024 | 154 | 0.050 |
Why?
|
| Child | 1 | 2023 | 25890 | 0.050 |
Why?
|
| Diet | 1 | 2009 | 1195 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 29 | 0.050 |
Why?
|
| Dronabinol | 1 | 2022 | 33 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1736 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 426 | 0.040 |
Why?
|
| Cytokines | 2 | 2018 | 1401 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2010 | 2738 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 544 | 0.040 |
Why?
|
| C-Peptide | 1 | 2020 | 116 | 0.040 |
Why?
|
| Leptin | 1 | 2020 | 224 | 0.040 |
Why?
|
| Callithrix | 1 | 2018 | 14 | 0.040 |
Why?
|
| Mutation | 1 | 2012 | 6338 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 116 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2017 | 100 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 136 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 20624 | 0.030 |
Why?
|
| Tobacco Products | 1 | 2017 | 72 | 0.030 |
Why?
|
| Kidney | 1 | 2024 | 1421 | 0.030 |
Why?
|
| Infant | 1 | 2012 | 13240 | 0.030 |
Why?
|
| Giant Cells | 1 | 2017 | 36 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 402 | 0.030 |
Why?
|
| Mucus | 1 | 2016 | 38 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 85 | 0.030 |
Why?
|
| Gravidity | 1 | 2016 | 12 | 0.030 |
Why?
|
| Population | 1 | 2016 | 24 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2017 | 111 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2016 | 145 | 0.030 |
Why?
|
| CCCTC-Binding Factor | 1 | 2016 | 24 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 237 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2018 | 538 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 134 | 0.030 |
Why?
|
| Environment Design | 1 | 2015 | 17 | 0.030 |
Why?
|
| Geographic Mapping | 1 | 2015 | 15 | 0.030 |
Why?
|
| Dengue | 1 | 2017 | 122 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 41 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 572 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 77 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2015 | 198 | 0.030 |
Why?
|
| Insulin | 1 | 2020 | 1260 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 314 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2017 | 563 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 170 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2016 | 5222 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 785 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 839 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2013 | 38 | 0.030 |
Why?
|
| Genome | 1 | 2016 | 528 | 0.030 |
Why?
|
| Beverages | 1 | 2013 | 102 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1340 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1338 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 868 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2016 | 489 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 732 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2016 | 700 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 667 | 0.020 |
Why?
|
| Hemolymph | 1 | 2010 | 4 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 874 | 0.020 |
Why?
|
| Hemorheology | 1 | 2010 | 28 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3188 | 0.020 |
Why?
|
| Rheology | 1 | 2010 | 38 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1258 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2010 | 10 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 2684 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6601 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2814 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 2218 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3798 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 1631 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 2137 | 0.020 |
Why?
|
| Stents | 1 | 2015 | 877 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 1196 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 468 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 68 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 3043 | 0.020 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2009 | 86 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 4879 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2009 | 110 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2947 | 0.020 |
Why?
|
| Contrast Media | 1 | 2010 | 518 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 243 | 0.020 |
Why?
|
| Skin | 1 | 2009 | 545 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 13074 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17540 | 0.010 |
Why?
|